Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call
Globenewswire· 2026-10-21 20:30
MALVERN, Pa., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that it plans to release third quarter 2026 financial and operating results prior to market open on Wednesday, November 4, 2026. The Company will host a conference call to review its results at 8:30 a.m. Eastern Time the same day.The c ...
Apollo partners with Generali to launch Red Bridge Syndicate 2031
Globenewswire· 2026-10-21 20:30
LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Apollo, a Skyward Group company (Nasdaq: SKWD), an innovation-inspired insurance platform, today announced it has partnered with Generali to launch a new platform partner syndicate for which it will act as managing agent. Red Bridge Syndicate 2031 has received “in-principle” approval from Lloyd's and is expected to begin underwriting on 1 January 2027. Red Bridge will provide an opportunity for Lloyd’s members to share in Generali's highly diversified outward reinsu ...
JP3E Holdings Inc. Completes Acquisition of Demora Foundation: 100% Ownership, Strengthening Global Blockchain and RWA Tokenization Infrastructure
Globenewswire· 2026-10-21 20:30
With the remaining 39% ownership of Demora Foundation, consolidating 100% ownership of its institutional blockchain infrastructure, JP3E advances the K2Global SMB 500 initiativeTRENTON, N.J. and SEOUL, South Korea, Oct. 21, 2026 (GLOBE NEWSWIRE) -- JP3E Holdings Inc. (OTC: JPTE) ("JP3E" or the "Company") today announced the completion of its acquisition of the remaining 39% ownership interest in Demora Foundation, increasing its total ownership from 61% to 100%. As a result of the transaction, Demora Founda ...
Lexicon Pharmaceuticals Announces Publication of New Research Highlighting Sotagliflozin’s Biological Effects in Cardiovascular Disease
Globenewswire· 2026-10-21 20:30
-- Preclinical study demonstrates positive effects of sotagliflozin on cardiac function and structure in hypertrophic cardiomyopathy -- -- Second preclinical study shows inhibitory effects of sotagliflozin on platelet activity and thrombus formation -- -- Findings underscore differentiated biology associated with dual SGLT1 and SGLT 2 inhibition -- THE WOODLANDS, Texas, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today ...
Cycurion’s Digital Ally Secures $383,000 in New Midwest Law Enforcement Contracts as Special Operations and Intelligence Veterans Lead Renewal
Globenewswire· 2026-10-21 20:20
With new leadership and a renewed sense of purpose, Cycurion is bringing mission-focused tenacity and next-generation technology across the company, including to Digital Ally’s proven product line.MCLEAN, Va., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cycurion, Inc., a Delaware corporation (NASDAQ: CYCU) (“Cycurion” or the “Company”), a leading AI-driven, tech-enabled cybersecurity solutions provider, today announced continued growth in its Digital Ally video solutions business. Over the past 30 days, including Oct ...
VivoPower Signs Definitive Heads of Agreement with Open Innovation AI to Develop Secure Sovereign AI Data Centers Across the Nordics, Mainland Europe, the GCC and selective countries in Asia
Globenewswire· 2026-10-21 20:18
Agreement signed at Sheikh Zayed Museum in Abu Dhabi pairs VivoPower’s powered land and data center infrastructure capabilities with Open Innovation AI’s sovereign AI orchestration and security platform. The partners see a sovereign AI opportunity of more than 40GW in Europe alone, across government administration, defense, medical, educational and financial services sovereign cloud and will target at least 1GW of capacity over the next three years, with further demand across the GCC and Asia. VivoPower ...
IMUNON Announces Strategic Sale of ThermoDox®
Globenewswire· 2026-10-21 20:15
Agreement with VoxelDox Therapeutics, Inc. Creates a Clear Path to Future Value, Subject to Achievement of Development Milestones in the Planned Phase 1 Glioblastoma Trial Sale Reinforces IMUNON's Commitment to Its Core Strategy: Executing the Pivotal Phase 3 OVATION 3 Trial of IMNN-001 LAWRENCEVILLE, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that it has entered into an agreement to sel ...
Alpha Modus Highlights Bitcoin Holdings with Value Exceeding $250 Million*, Potential $225 Million in Additional Cash Proceeds, ARIA Expansion Targeting Over 20,000 Retail Locations and Significant Federal Patent Litigation Milestones
Globenewswire· 2026-10-21 20:15
Company underscores substantial digital asset holdings, potential $225 million in additional cash capitalization, AI commercialization opportunities targeting over 20,000 retail locations, and an expanding intellectual property enforcement strategy with multibillion-dollar potential CORNELIUS, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Modus Holdings, Inc. (NASDAQ: AMOD) (“Alpha Modus” or “the Company”) today provided an update on its digital asset holdings, ARIA, the Adaptive Retail Intelligence Archit ...
HII Increases Quarterly Dividend to $1.41 per Share
Globenewswire· 2026-10-21 20:15
NEWPORT NEWS, Va., Oct. 21, 2026 (GLOBE NEWSWIRE) -- HII (NYSE: HII) announced today that its Board of Directors has declared a quarterly cash dividend of $1.41 per share, a $0.03 increase over the $1.38 per share dividend paid in each of the prior four quarters. The $1.41 per share dividend will be payable on Dec. 11, 2026, to shareholders of record as of the close of business on Nov. 27, 2026. About HII Brooke Hart (Media) brooke.hart@hii.com 202-264-7108 Christie Thomas (Investors) christie.thomas@hii.co ...
Belo Sun Receives Decision on Temporary Suspension of License Until Result of Settlement Hearing
Globenewswire· 2026-10-21 20:13
TORONTO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (TSX: BSX) (OTCQX: BSXGF) (the “Company” or “Belo Sun”) announces that the Brazilian Supreme Court (“STF”) issued a decision on the request for suspension of provisional relief (Suspensão de Tutela Provisória) filed by Brazil’s Federal Public Prosecutor’s Office (“MPF”) concerning the Installation License (“LI”) for the Company’s Volta Grande Gold Project (the “Project”) in Pará, Brazil. The STF partially granted the MPF’s request, temporarily ...